Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
83.36 USD | -0.17% | +4.53% | +7.87% |
05-06 | Argus Adjusts Price Target on Bio-Techne to $95 From $90, Keeps Buy Rating | MT |
05-02 | UBS Adjusts Price Target on Bio-Techne to $90 From $80, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.87% | 13.16B | |
+33.56% | 49.46B | |
+1.79% | 42.58B | |
+49.11% | 42.49B | |
-4.22% | 29.09B | |
+11.77% | 26.61B | |
-21.72% | 18.64B | |
+29.47% | 12.55B | |
+23.83% | 12.1B | |
-4.37% | 11.98B |
- Stock Market
- Equities
- TECH Stock
- News Bio-Techne Corporation
- RBC Initiates Bio-Techne at Sector Perform, Sets Price Target at $89, Says Revenue Targets Look 'Too High'